PLMA_1170x120_9-1-21

20/20 BioResponse

20/20 launching first COVID-19 rapid antibody test authorized by FDA

20/20 launching first COVID-19 rapid antibody test authorized by FDA

ROCKVILLE, Md. — 20/20 BioResponse, a business unit of 20/20 GeneSystems, Inc., announced today that it is now accepting orders for the Assure COVID-19 IgG/IgM Rapid Test kits. These kits were the first to receive an emergency use authorization (EUA) from the FDA for point-of-care (POC) use with fingerstick blood samples on September 23. According to the FDA